# Study to Determine Safety and Dosage of OPTISON in Pediatric Participants

> **NCT03740997** · PHASE4 · COMPLETED · sponsor: **GE Healthcare** · enrollment: 39 (actual)

## Conditions studied

- Transthoracic Echocardiography
- Suspected or Known Structural or Functional Cardiac Abnormality

## Interventions

- **DRUG:** Optison

## Key facts

- **NCT ID:** NCT03740997
- **Lead sponsor:** GE Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2023-03-30
- **Final completion:** 2023-03-30
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2024-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03740997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03740997, "Study to Determine Safety and Dosage of OPTISON in Pediatric Participants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03740997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*